source
- FDA extends review of Capricor cell therapy; Pain drug startup to go publicThe agency is now reviewing an updated application for deramiocel with a “refined” indication. Elsewhere, a startup co-founded by Vivek Ramaswamy is taking a speedy path to the public markets.BioPharma Dive · 1h ago↗ source
- Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood testRoche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.Fierce Biotech · 9h ago↗ source
- Activist Kaos Capital pushes governance overhaul at Capricor ahead of FDA Duchenne decisionActivist investor Kaos Capital has sent a letter to Capricor Therapeutics shareholders demanding a “governance reset.” The firm asks for a meeting to nominate two independent directors, create an M…